window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 19, 2026

  • News
  • About Us
Contact Us

Cell Therapy

  • Cell & Gene Therapy,Clinical Development,Clinical Trials,Oncology,Research & Development

    CERo reports early safety signals and platelet transfusion-free interval in Phase 1 AML trial

    CERo Therapeutics has reported early clinical findings from its ongoing [...]

    January 9, 2026
  • Biotech,Global health,Research & Development,Technology and platforms

    ICON 2025 global biotech survey shows China leading innovation and highlights Western opportunities

    ICON plc has released findings from its 2025 global biotech [...]

    December 11, 2025
  • Biotech,Market Access & Commercialization,Oncology,Partnerships & Funding,Research & Development

    Cue Biopharma and ImmunoScape partner on novel in vivo cell therapy for solid tumours

    Cue Biopharma and ImmunoScape have entered an exclusive collaboration and [...]

    November 6, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics

    NurExone joins ARMI BioFab Startup Lab to boost US regenerative manufacturing

    NurExone Biologic Inc has been accepted into the BioFab Startup [...]

    November 5, 2025
  • Cell & Gene Therapy,Oncology,Orphan drugs,Regulatory Affairs

    Minovia Therapeutics gains FDA orphan drug designation for MNV-201 in myelodysplastic syndrome

    Minovia Therapeutics has received orphan drug designation from the US [...]

    October 17, 2025
  • Biotech,Cell & Gene Therapy,Clinical Trials,Mergers & Acquisitions

    Alvarez & Marsal appointed to oversee TC BioPharm as sale of business and assets begins

    Alvarez & Marsal has been appointed as joint administrators of [...]

    October 8, 2025
  • Biotech,Oncology,Regulatory Affairs

    Orca Bio’s Orca-T receives FDA Priority Review for blood cancer treatment

    The US Food and Drug Administration (FDA) has accepted for [...]

    October 7, 2025
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    CTMC and Einstein Hospital Israelita launch global cell therapy alliance

    CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

    October 2, 2025
  • Biomanufacturing,Biotech,Cell & Gene Therapy,Clinical Development,Pharmaceuticals and therapeutics,Research & Development

    BioGrad unveils state-of-the-art Liverpool bio-manufacturing centre to drive cell and gene therapy growth in the North

    BioGrad has announced plans for a new Centre of Bio-Manufacturing [...]

    September 26, 2025
  • Cell & Gene Therapy,Chronic diseases,Clinical Development,Pharmaceuticals and therapeutics

    Persista Bio wins NIH funding to advance O2Line cell therapy

    Persista Bio has been awarded two grants from the US [...]

    September 24, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth
    Categories: Biotech, Clinical Development, Clinical studies, Clinical Trials, Healthcare leadership, Movers & Shakers, Rare Diseases
  • Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations
    Categories: Biomanufacturing, CDMOs & Manufacturing, Healthcare leadership, Movers & Shakers, Pharmaceuticals and therapeutics
  • CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
    Categories: Artificial Intelligence, Biotech, Drug Development, Mergers & Acquisitions, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top